Latest in Pfizer Tops Earnings
Sort by
1,318 items
-
Pfizer tops earnings estimates, hikes full-year guidance as Covid products help sales
It is a critical quarterly report for Pfizer, which is grappling with activist pressure from Starboard Value.Business - CNBC - October 29 -
Pfizer’s earnings crush estimates as company raises guidance
Drug company Pfizer saw strong growth for its heart-disease drugs and migraine treatment.Business - MarketWatch - October 29 -
Comcast tops earnings estimates as Olympics propel the company
Comcast beat third-quarter earnings estimates as the Summer Olympics in Paris boosted NBCUniversal’s revenue and Peacock’s subscriber count.Business - CNBC - October 31 -
How top lawyers earn their bragging rights on pay
Arrival of US firms has pushed up top UK law firms’ charge-out rates by almost 40% in five yearsBusiness - Financial Times - November 3 -
Biogen’s stock hit by soft sales of Alzheimer’s treatment
“We continue to see momentum with ongoing product launches and we are increasingly excited about the potential of our pipeline,” the company’s CEO said.Business - MarketWatch - October 30 -
Meta sees AI spending accelerating as earnings top forecasts
Mark Zuckerberg cites the potential for ‘strong’ returns in coming years on heavy investments in new technologyBusiness - Financial Times - October 31 -
Bristol Myers’s stock pops as earnings top estimates and company raises guidance
The company says it “made important strides in the third quarter.”Business - MarketWatch - October 31 -
AppLovin, top tech stock of the year, soars another 46% on earnings beat
AppLovin was already the best-performing tech stock of 2024, and that was before the stock popped on a big earnings beat.Business - CNBC - November 7 -
AP Top 25: TCU earns best ranking in 16 years in women's basketball poll as top 12 remain unchanged
TCU has entered The Associated Press Top 25 women's basketball poll at No. 19, the school's best ranking in 16 yearsSports - ABC News - November 18 -
Pfizer’s guidance bump will not heal deeper wounds
Starboard is right to take drugmaker to task for bingeing on overpriced dealsBusiness - Financial Times - October 29 -
Pfizer's Strong Quarter Bolsters CEO's Comeback Efforts
The pharmaceutical company reported its third consecutive quarter with positive results.Business - The Wall Street Journal - October 29 -
Pfizer Names New R&D Chief
Company veteran Chris Boshoff, who has led Pfizer’s cancer research and marketing for more than a year, will become chief scientific officer starting Jan. 1.Business - The Wall Street Journal - 6 days ago -
Ford guides to low end of 2024 earnings forecast as it slightly tops Wall Street's third-quarter expectations
Ford guides to low end of 2024 earnings forecast as it slightly tops Wall Street's Q3 expectationsBusiness - CNBC - October 29 -
Bitcoin rises 3% after topping $73,000 for the first time since March
Bitcoin has struggled to reclaim the $70,000 level this year after reaching a record of $73,797.68 in March.Business - CNBC - October 29 -
Carvana raises 2024 earnings guidance after topping Wall Street's Q3 expectations
Carvana said its adjusted EBITDA would be "significantly above the high end" of its previous target of $1 billion to $1.2 billion.Business - CNBC - October 30 -
Samsung falls short of expectations as chipmaker fails to reap AI benefits
Third-quarter operating profit far lower than analyst consensus and trails domestic rival SK HynixWorld - Financial Times - October 31 -
Donald Trump and the autocrats' playbook
‘This is a man who should be nowhere near power’World - Financial Times - October 31 -
UK Labour’s Budget borrows big, taxes more
Chancellor Rachel Reeves announced a £40bn tax increase and a sharp rise in borrowingWorld - Financial Times - October 31 -
Bank of Japan holds rates but signals normalisation still on track
Political uncertainty following election upset raises risks of abrupt policy shifts, warn analystsWorld - Financial Times - October 31 -
FirstFT: US consumers continue to spend, spend, spend
Also in today’s newsletter, North Korea fires its longest-ever test missile, and the activists ready to challenge the election resultWorld - Financial Times - October 31 -
Stellantis hit by sales slide in US and Europe
Fiat, Jeep and Peugeot owner suffers 27% drop in third-quarter sales but signals improvement to US inventoryWorld - Financial Times - October 31 -
Merck tops earnings estimates on strong demand for Keytruda, new drugs even as HPV vaccine sales fall
The company saw strong sales from its top-selling cancer drug Keytruda, recently launched treatments and its animal health business.Business - CNBC - October 31 -
Bristol Myers Squibb tops earnings estimates and hikes outlook, helped by Eliquis and new drugs
The pharmaceutical giant also raised its full-year revenue forecast to an increase of roughly 5%.Business - CNBC - October 31 -
Peloton’s stock soars 30% after company names Apple Fitness+ co-founder as new CEO
Peloton announced the appointment of Peter Stern as new CEO effective Jan. 1. Stern is the co-founder of Apple Fitness+ and has done stints at Ford Motor Co. and Time Warner Cable.Business - MarketWatch - October 31 -
Micron tops list of 20 biggest winners in the S&P 500 this earnings season
Other companies showing very high sales growth with improving profit margins include BlackRock and Eli Lilly.Business - MarketWatch - November 8 -
Nordstrom tops Wall Street’s earnings expectations, as shoppers buy more clothes and shoes
The retailer's sales growth is notable at a time when discretionary merchandise and the luxury sector have been under pressure.Business - CNBC - 8 hours ago -
How are investors preparing for the Budget?
Executives are seeking to minimise their exposure ahead of what could be the biggest tax-raising statement for a generationBusiness - Financial Times - October 29 -
Pfizer CEO defends performance after Starboard activist criticism
Drugmaker boosts full-year sales and profit forecasts after reporting better than expected earningsBusiness - Financial Times - October 29 -
Pfizer names oncology chief and company veteran Boshoff as chief scientific officer
The drug company had been searching for a new chief scientific officer since July with Mikael Dolsten leaving after 15 years at the company.Business - MarketWatch - 6 days ago -
Pfizer CEO says he welcomes good ideas as Starboard ups pressure on company
Pfizer reported an earnings beat Tuesday morning and raised its full-year outlook, seeing strength in sales of its Covid vaccine and antiviral pill, Paxlovid.Business - CNBC - October 29 -
Vaccine-maker stocks like Moderna, Pfizer drop as Trump picks RFK Jr. to lead HHS
Shares of vaccine makers lost ground Thursday, hit by news that President-elect Donald Trump was naming vaccine skeptic and former presidential hopeful Robert F. Kennedy Jr. as his pick to lead the ...Business - MarketWatch - November 14 -
TJX boosted by strength in Europe, as retailer posts earnings beat and raises guidance
TJX Cos.’ stock was flat in afternoon trade Wednesday after rising from its morning lows, which came even after the discount retailer’s fiscal third-quarter earnings topped estimates and it again ...Business - MarketWatch - 6 days ago -
PayPal shares fall on revenue miss, soft guidance
PayPal reported better-than-expected third-quarter earnings on Tuesday, but revenue came in slightly below expectations.Business - CNBC - October 29 -
Alphabet shares rise on earnings beats boosted by cloud revenue
Google parent Alphabet reported third-quarter earnings that beat on top and bottom lines.Business - CNBC - October 30 -
Meta misses on user growth, warns of 2025 jump in AI spending
Meta reported weaker-than-expected user numbers and warned of a significant acceleration in its infrastructure expenses in 2025 in its third-quarter earnings.Business - CNBC - October 30 -
Microsoft Cloud revenue rises on AI boom but softer outlook weighs on shares
Warnings of slowing Azure growth and rising data centre costs damp initial optimism on tech giant’s quarterly earningsBusiness - Financial Times - October 31
